Suzuki Osamu, Goto Taiji, Yoshino Toshiharu, Nakamura Satoshi, Maeda Hiroaki
Acta Pharm. 2015 Jun;65(2):191-7. doi: 10.1515/acph-2015-0016.
PDE4B was previously shown to be a dominant PDE4 subtype of neutrophils. However, its physiological role in the neutrophil function has not been evaluated. In this study, the inhibitory effects of a phosphodiesterase 4B (PDE4B)- selective inhibitor (compound A) and subtype non-selective PDE4 inhibitors (roflumilast and cilomilast) were evaluated in human peripheral blood cells. Compound A, roflumilast and cilomilast in a similar manner inhibited TNF-α production by LPS-stimulated human mononuclear cells. However, the inhibitory effect of compound A on IL-8 or LTB4-induced chemotactic response of neutrophils was modest even at the highest concentration (10 μmol L(-1)), whereas roflumilast and cilomilast inhibited IL-8 or LTB4-induced neutrophil chemotaxis. Our results suggest that PDE4B does not play an important role during the chemotactic response of human neutrophils.
磷酸二酯酶4B(PDE4B)此前被证明是中性粒细胞的主要PDE4亚型。然而,其在中性粒细胞功能中的生理作用尚未得到评估。在本研究中,在人外周血细胞中评估了磷酸二酯酶4B(PDE4B)选择性抑制剂(化合物A)和亚型非选择性PDE4抑制剂(罗氟司特和西洛司特)的抑制作用。化合物A、罗氟司特和西洛司特以类似方式抑制脂多糖刺激的人单核细胞产生肿瘤坏死因子-α(TNF-α)。然而,即使在最高浓度(10 μmol L(-1))下,化合物A对白细胞介素-8(IL-8)或白三烯B4(LTB4)诱导的中性粒细胞趋化反应的抑制作用也很微弱,而罗氟司特和西洛司特抑制IL-8或LTB4诱导的中性粒细胞趋化作用。我们的结果表明,PDE4B在人中性粒细胞的趋化反应中不发挥重要作用。